DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Benzinga·07/25/2025 12:34:46
Listen to the news

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.

Shares of Intel Corporation (NASDAQ:INTC) fell in pre-market trading following second-quarter results.

Intel reported a loss for the second quarter, while sales topped estimates. Intel expects third-quarter revenue to be in the range of $12.6 billion to $13.6 billion, versus estimates of $12.63 billion. The company anticipates a third-quarter loss of 24 cents per share versus estimates for a loss of 18 cents per share. Intel CEO Lip-Bu Tan shared a memo with employees saying that the company will reduce its workforce to 75,000 employees by the end of the year through layoffs and attrition.

Intel shares dipped 5.9% to $21.30 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

  • Absci Corporation (NASDAQ:ABSI) declined 13.7% to $3.03 in pre-market trading after the company announced the pricing of public offering of common stock.
  • AST SpaceMobile, Inc. (NASDAQ:ASTS) fell 9.2% to $54.56 in pre-market trading after the company announced a $500 million private offering of convertible senior notes.
  • Almonty Industries Inc. (NASDAQ:ALM) dipped 8.5% to $4.06 in pre-market trading.
  • Synovus Financial Corp. (NYSE:SNV) fell 8.3% to $51.88 in pre-market trading. Pinnacle and Synovus announced an $8.6 billion all-stock merger.
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) declined 5.2% to $12.20 in pre-market trading. Citigroup analyst Yigal Nochomovitz, on Thursday, initiated coverage on Sarepta Therapeutics with a Sell rating and announced a price target of $7.
  • ABIVAX Société Anonyme (NASDAQ:ABVX) fell 4% to $66.99 in pre-market trading. Abivax announced full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5 million (€637.5 million).
  • Semler Scientific, Inc. (NASDAQ:SMLR) fell 3.6% to $37.50 in pre-market trading.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.